Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Geltman

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
The New England Journal of Medicine|March 18, 1993
A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigatorsJ L Rouleau, L A Moyé, M A Pfeffer, et al.
JAMA|July 24, 1991
Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE InvestigatorsM A Pfeffer, L A Moyé, E Braunwald, et al.
Circulation|February 23, 2000
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure TrialT B Levine, P J Bernink, A Caspi, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
The New England Journal of Medicine|March 18, 1993
A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigatorsJ L Rouleau, L A Moyé, M A Pfeffer, et al.
JAMA|July 24, 1991
Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE InvestigatorsM A Pfeffer, L A Moyé, E Braunwald, et al.
Circulation|February 23, 2000
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure TrialT B Levine, P J Bernink, A Caspi, et al.
Pageof 7